COVID-19: Risk groups, mechanistic insights and challenges.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Correlation between Previous Antibiotic Exposure and COVID-19 Severity. A Population-Based Cohort Study.Antibiotics (Basel, Switzerland) · 2021
   Article
2. Changes in physical activity and basic psychological needs related to mental health among people with physical disability during the COVID-19 pandemic in Norway.Disability and health journal · 2021
   Article
3. COVID-19: breaking down a global health crisis.Annals of clinical microbiology and antimicrobials · 2021
   Review
4. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.Orphanet journal of rare diseases · 2021
   Article
5. Effect of COVID-19 Lockdown on Dietary Habits and Lifestyle of Food Science Students and Professionals from Spain.Nutrients · 2021
   Article
6. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?American journal of physiology. Lung cellular and molecular physiology · 2020
   Article
7. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
   Review
8. [Basic principles of replication and immunology of SARS-CoV-2].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
   Review
9. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?Autoimmunity reviews · 2020
   Article
10. Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients.Frontiers in physiology · 2020
    Review

Corrections and comments

• Comment on
  COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as